Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this first episode, Dr. Linda-Gail Bekker and Ms. Maureen Luba discuss why an HIV vaccine remains the ultimate game-changer to ending the epidemic and the gaps it will address in the expanding HIV prevention landscape.Presenters:Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD Chief Operating Officer Desmond Tutu HIV Foundation Deputy DirectorDesmond Tutu HIV Centre Past PresidentInternational AIDS Society Faculty of Health Sciences University of Cape Town Cape Town, South AfricaMaureen LubaAfrica Region Advocacy AdvisorGlobal Advocacy for HIV PreventionAIDS Vaccine Advocacy CoalitionLink to full series:https://bit.ly/3ytytMYLink to the HIV unmuted series from IAS:https://bit.ly/3f5qC0dContent is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related